By Jonathan Stempel NEW YORK, Feb 23 (Reuters) - Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely ...

A patient has died in a mid-stage study of MacroGenics’ bispecific antibody lorigerlimab in gynecologic cancers, prompting ...

Mental health linked to higher risk of death in cancer patients - Charities and researchers have called for mental health screening for people diagnosed with cancer ...

The FDA has placed a partial clinical hold on a cancer drug trial following four safety events, including one death, according to a Feb. 25 announcement from MacroGenics.  The partial hold pauses ...

Cancer patients who develop mental health issues within a year of diagnosis face a 50% higher risk of death, new research ...

The FDA has ordered MacroGenics to halt enrollment in a phase 2 trial of the biotech’s lead candidate lorigerlimab following severe side effects that led to one patient's death.

Aaron Dalton, whose wife died from liver cancer, is heading to Parliament to demand better NHS care, as data shows 2 in 3 ...

News, features, and commentary about cancer-related issues ...

In a study of adults with cancer, those who developed a mental health condition within the first year after their cancer ...

Research shows that cancer survivors can lower their risk of death with increased physical activity. Here's what Black cancer ...

The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic ...

By Dr. Priyom Bose, Ph.D. For many patients, the emotional toll of cancer can become a hidden risk factor, one that may influence survival as much as the disease itself. Study: Association of mental ...